Pascal Claudepierre

6.7k total citations · 1 hit paper
186 papers, 3.2k citations indexed

About

Pascal Claudepierre is a scholar working on Rheumatology, Immunology and Orthopedics and Sports Medicine. According to data from OpenAlex, Pascal Claudepierre has authored 186 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Rheumatology, 84 papers in Immunology and 30 papers in Orthopedics and Sports Medicine. Recurrent topics in Pascal Claudepierre's work include Spondyloarthritis Studies and Treatments (139 papers), Rheumatoid Arthritis Research and Therapies (95 papers) and Psoriasis: Treatment and Pathogenesis (80 papers). Pascal Claudepierre is often cited by papers focused on Spondyloarthritis Studies and Treatments (139 papers), Rheumatoid Arthritis Research and Therapies (95 papers) and Psoriasis: Treatment and Pathogenesis (80 papers). Pascal Claudepierre collaborates with scholars based in France, Netherlands and United States. Pascal Claudepierre's co-authors include Maxime Dougados, Daniel Wendling, Xavier Chevalier, Désirée van der Heijde, Alain Saraux, Anna Moltó, M. Reijnierse, A. Feydy, Martín Rudwaleit and É. Sbidian and has published in prestigious journals such as PLoS ONE, Neurology and Clinical Infectious Diseases.

In The Last Decade

Pascal Claudepierre

164 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database

2022 99 citations Léa Hoisnard, Bénédicte Lebrun‐Vignes et al. Scientific Reports profile →

Peers

Countries citing papers authored by Pascal Claudepierre

Since Specialization

Citations

This map shows the geographic impact of Pascal Claudepierre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Claudepierre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Claudepierre more than expected).

Fields of papers citing papers by Pascal Claudepierre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Claudepierre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Claudepierre. The network helps show where Pascal Claudepierre may publish in the future.

Co-authorship network of co-authors of Pascal Claudepierre

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Claudepierre. A scholar is included among the top collaborators of Pascal Claudepierre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Claudepierre. Pascal Claudepierre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study 2024 ·RMD Open ·Maxime Dougados, Audrey Lardy-Cléaud, (unknown), Pascal Claudepierre, Philippe Goupille, (unknown), Alain Saraux, Anne Tournadre, Daniel Wendling, Cédric Lukas	1
2	Diagnosis challenges in inception cohorts in axial spondyloarthritis: the case of the French national DESIR cohort 2024 ·RMD Open ·Anna Moltó, (unknown), Sandrine Alonso, Francis Bérenbaum, Pascal Claudepierre, Bernard Combe, Laure Gossec, Adeline Ruyssen‐Witrand, Alain Saraux, Daniel Wendling, Thierry Lequerré, Maxime Dougados	1
3	Bone marrow edema in the sacroiliac joints is associated with the development of structural lesions at the same anatomical location over time in patients with axial spondyloarthritis 2023 ·Seminars in Arthritis and Rheumatism ·Santiago Rodrigues-Manica, Alexandre Sepriano, Sofía Ramiro, Robert Landewé, Pascal Claudepierre, Anna Moltó, Maxime Dougados, M. van Lunteren, Désirée van der Heijde	2
4	Ten-year clinical outcome of recent-onset axial spondyloarthritis: Results from the DESIR inception Cohort 2023 ·Joint Bone Spine ·Maxime Dougados, (unknown), Sandrine Alonso, Francis Bérenbaum, Pascal Claudepierre, Bernard Combe, Laure Gossec, (unknown), Alain Saraux, Daniel Wendling, (unknown), Anna Moltó	4
5	Development and Validation of a Self-Administered Questionnaire Measuring Essential Knowledge in Patients With Axial Spondyloarthritis 2022 ·The Journal of Rheumatology ·Catherine Beauvais, Bruno Pereira, Thao Pham, Christelle Sordet, Pascal Claudepierre, Françoise Fayet, Daniel Wendling, Félicie Costantino, Laurence Carton, Laurent Grange, Martin Soubrier, N. Legoupil, Aleth Perdriger, (unknown), Emmanuelle Dernis, Laure Gossec, (unknown)	4
6	Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database breakdown → 2022 ·Scientific Reports ·Léa Hoisnard, Bénédicte Lebrun‐Vignes, Sébastien Maury, Matthieu Mahévas, Khalil El Karoui, Lydia Roy, (unknown), Marc Michel, José L. Cohen, Aurélien Amiot, Pascal Claudepierre, P. Wolkenstein, Philippe Grimbert, É. Sbidian	99
7	5-year follow-up of spinal and sacroiliac MRI abnormalities in early axial spondyloarthritis: data from the DESIR cohort 2020 ·RMD Open ·(unknown), Alexandre Sepriano, Sofía Ramiro, Anna Moltó, Pascal Claudepierre, Daniel Wendling, Maxime Dougados, Désirée van der Heijde, F. van Gaalen	12
8	Spinal-pelvic orientation: potential effect on the diagnosis of spondyloarthritis 2019 ·Lara D. Veeken ·Guillermo Carvajal Alegria, (unknown), (unknown), (unknown), Laure Gossec, Alexandre Simon, A. Feydy, M. Reijnierse, Désirée van der Heijde, Damien Lœuille, Pascal Claudepierre, Thierry Marhadour, Alain Saraux	3
9	Evaluation of the change in structural radiographic sacroiliac joint damage after 2 years of etanercept therapy (EMBARK trial) in comparison to a contemporary control cohort (DESIR cohort) in recent onset axial spondyloarthritis 2018 ·Annals of the Rheumatic Diseases ·Maxime Dougados, Walter P. Maksymowych, Robert Landewé, Anna Moltó, Pascal Claudepierre, Manouk de Hooge, R. Lambert, R. Bonin, Jack F. Bukowski, Heather Jones, I. Logeart, Ron Pedersen, Annette Szumski, Bonnie Vlahos, Désirée van der Heijde	33
10	The epidemiology of rheumatic disorders in a rural area of the Democratic Republic of Congo (DRC): A COPCORD study 2017 ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Pascal Claudepierre, Benjamin Longo‐Mbenza, (unknown)	2
11	Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study 2017 ·Annals of the Rheumatic Diseases ·Anna Moltó, Adrien Etcheto, Laure Gossec, (unknown), Pascal Claudepierre, Nicolas Roux, (unknown), Antoine Martin, (unknown), Pascal Coquerelle, Martin Soubrier, Serge Perrot, Maxime Dougados	77
12	Assessment of typical SpA lesions on MRI of the spine: do local readers and central readers agree in the DESIR-cohort at baseline? 2017 ·Clinical Rheumatology ·Manouk de Hooge, Jean‐Baptiste Pialat, M. Reijnierse, Désirée van der Heijde, Pascal Claudepierre, Alain Saraux, Maxime Dougados, A. Feydy	9
13	Can we use structural lesions seen on MRI of the sacroiliac joints reliably for the classification of patients according to the ASAS axial spondyloarthritis criteria? Data from the DESIR cohort 2016 ·Annals of the Rheumatic Diseases ·P. Bakker, Rosaline van den Berg, G. Lenczner, F. Thévenin, M. Reijnierse, Pascal Claudepierre, Daniel Wendling, Maxime Dougados, Désirée van der Heijde	46
14	Prevalence, Comorbidities and Burden of Severe Spondyloarthritis In France: Analysis of A National Public Health Insurance Database In 2012 In France 2015 ·Value in Health ·Pascal Claudepierre, Maxime Bréban, (unknown), Jean-Michel Joubert, (unknown), J. Gourmelen, Francis Fagnani	1
15	Is It Worth to Include MRI of the Spine in the ASAS Classification Criteria for Axial Spondyloarthritis 2014 ·Arthritis & Rheumatism ·Manouk de Hooge, J Pialat, A. Feydy, M. Reijnierse, Pascal Claudepierre, A Saraux, Maxime Dougados, D. van der Heijde	0
16	Effectiveness of adalimumab in treating patients with ankylosing spondylitis associated with enthesitis and peripheral arthritis 2010 ·Arthritis Research & Therapy ·Martín Rudwaleit, Pascal Claudepierre, Martina Kron, S. Kary, Robert Wong, H. Küpper	27
17	Agents anti-TNFα et traitement des spondylarthropathies 2007 ·Daniel Wendling, Pascal Claudepierre, Éric Toussirot, Gérald Streit, Clément Prati, Paul Ornetti	1
18	The familial form of spondylarthropathy: A clinical study of 115 multiplex families 2000 ·Arthritis & Rheumatism ·Roula Said‐Nahal, Corinne Miceli‐Richard, Jean‐Marie Berthelot, (unknown), (unknown), (unknown), Alain Saraux, Aleth Perdriger, Sandrine Guis, Pascal Claudepierre, Jean Sibilia, B Amor, M. Dougados, Maxime Bréban	95
19	Features associated with juvenile onset of spondylarthropathies in north Africa. 1996 ·PubMed ·Pascal Claudepierre, A Guéguen, (unknown), N. Hajjaj‐Hassouni, Slaheddine Sellami, B Amor, Maxime Dougados	6
20	[Posterior thoracic spinal tuberculosis: assessment by x-ray computed tomography and magnetic resonance imaging apropos of a case]. 1991 ·PubMed ·Pierre Brugières, Yvon Chevalier, Pascal Claudepierre, Hubert Ducou Le Pointe, André Gaston	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact